Skip to content

Patient Satisfaction and Visual Outcomes After Bilateral PanOptix Implantation in Patients With Previous Multifocal Contact Lens

Patient Satisfaction and Visual Outcomes After Bilateral PanOptix Implantation in Patients With Previous Multifocal Contact Lens

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05518227
Enrollment
12
Registered
2022-08-26
Start date
2023-01-19
Completion date
2024-07-24
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

To evaluate spectacle independence and patient satisfaction and visual outcomes after bilateral PanOptix implantation in patients with previous multifocal contact lens experience.

Detailed description

This study is a single-arm unmasked clinical evaluation study of patient satisfaction after successful bilateral cataract surgery. Subjects will be assessed pre-operatively, operatively and at 1 day, 1 week and 3 months post-operatively. Clinical evaluations will include administration of a visual disturbance questionnaire (QUVID), and a satisfaction questionnaire (IOLSAT), as well as measurement of bilateral visual acuity and manifest refraction.

Interventions

Bilateral implantation with the Clareon PanOptix Trifocal (toric and non-toric models)

Sponsors

Sengi
CollaboratorINDUSTRY
Vivid Laser Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

Subjects are eligible for the study if they meet the following criteria: Note: Ocular criteria must be met in both eyes. * Adult cataract patients undergoing uncomplicated cataract surgery with Clareon PanOptix IOL implantation (non-toric/toric). * Visually significant cataracts bilaterally. * History of successful soft multifocal contact lens use in the past (within ≤ last 5 years). * Healthy ocular exam. * Gender: Males and Females. * Willing and able to provide written informed consent for participation in the study. * Willing and able to comply with scheduled visits and other study procedures.

Exclusion criteria

If any of the following

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction questionnaire3 months postoperativeThe Intraocular Lens Satisfaction questionnaire (IOLSAT). Lower scores indicate higher spectacle independence and satisfaction.

Secondary

MeasureTime frameDescription
Binocular uncorrected distance visual acuity (6m)3 months postoperative
Binocular uncorrected intermediate visual acuity (60 cm)3 months postoperative
Binocular uncorrected near visual acuity (40 cm)3 months postoperative
Binocular corrected distance visual acuity (6m)3 months postoperative
Manifest refraction3 months postoperative
Spectacle independence3 months postoperativeThe Intraocular Lens Satisfaction questionnaire (IOLSAT). Lower scores indicate higher spectacle independence and satisfaction.
Binocular distance corrected intermediate visual acuity (60 cm)3 months postoperative
Binocular distance corrected intermediate visual acuity (40 cm)3 months postoperative

Other

MeasureTime frameDescription
Binocular distance corrected intermediate visual acuity (33 cm)3 months postoperative
Visual disturbances questionnaire3 months postoperativeQuestionnaire for Visual Disturbances (QUVID). Lower scores indicate less frequent, severe, or bothersome visual disturbances.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026